Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes

This study has been performed in diabetic type 2 patients with pain due to peripheral artery disease (PAD) in order to evaluate the efficacy and tolerability of tapentadol prolonged release (PR). Methods. 25 patients with type 2 diabetes (13 F and 12 M) were admitted in the study. The evaluation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tedeschi, Anna, De Bellis, Alessandra, Francia, Piergiorgio, Bernini, Arianna, Perini, Marco, Salutini, Elisabetta, Anichini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838502/
https://www.ncbi.nlm.nih.gov/pubmed/29675431
http://dx.doi.org/10.1155/2018/1081792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838502/
https://www.ncbi.nlm.nih.gov/pubmed/29675431
http://dx.doi.org/10.1155/2018/1081792

Ejemplares similares